Search Results
Search
Containing item
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
Creator: Chung, Alexander H, Leisner, Tina M, Dardis, Gabrielle J, Bivins, Marissa M, Keller, Alana L, Parise, Leslie V
Abstract Background Patients diagnosed with triple negative breast cancer (TNBC) have limited treatment options and often suffer from resistance and toxicity due to chemotherapy. We previously found that (more)
pdf (2.2 MB)
12935_2019_740_moesm1_esm.xlsx
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
xlsx (50 KB)
12935_2019_740_moesm2_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_740_moesm3_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_740_moesm4_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_740_moesm5_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_740_moesm6_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_740_moesm7_esm.tiff
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
tiff (11.1 MB)
12935_2019_article_740.pdf
Collection: BioMed Central
Date Deposited: 2019-02-09
Date Created: 2019-02-09
pdf (2.2 MB)
